Kazunori Maruyama

Biography

 Dr. Maruyama joined Astellas Venture Management (AVM) in December 2015. Prior to AVM, he served as Director, Business Development or similar function at Astellas Pharma (Tokyo) since 2008, where he led a number of strategic deals covering research collaboration with acquisition option, co-promotion in Japanese market, IP license and equity investment in the public US biotech company. Dr. Maruyama was one of the founding members of corporate venture fund in Yamanouchi Pharmaceutical (now Astellas Pharma) in 2001 and deeply contributed to expand its investment portfolio since 2003 to 2007 with nine biotech companies in the US and Europe, which ended up with one IPO and three M&A exits as of today. He started his job career as a research scientist at Yamanouchi in 1991 with background on biochemistry and molecular biology. Dr. Maruyama completed his Ph.D. thesis at the University of Tokyo in 1991 (Agricultural Chemistry).

Research Interest

 Dr. Maruyama joined Astellas Venture Management (AVM) in December 2015. Prior to AVM, he served as Director, Business Development or similar function at Astellas Pharma (Tokyo) since 2008, where he led a number of strategic deals covering research collaboration with acquisition option, co-promotion in Japanese market, IP license and equity investment in the public US biotech company. Dr. Maruyama was one of the founding members of corporate venture fund in Yamanouchi Pharmaceutical (now Astellas Pharma) in 2001 and deeply contributed to expand its investment portfolio since 2003 to 2007 with nine biotech companies in the US and Europe, which ended up with one IPO and three M&A exits as of today. He started his job career as a research scientist at Yamanouchi in 1991 with background on biochemistry and molecular biology. Dr. Maruyama completed his Ph.D. thesis at the University of Tokyo in 1991 (Agricultural Chemistry).